Skip to main content
. 2021 Sep 15;13(9):1474. doi: 10.3390/pharmaceutics13091474

Figure 1.

Figure 1

Immunofluorescence images presenting key markers of iBMEC microfluidic chip on day 3. (A) Claudin-5, (B) ZO-1, (C) glucose transporter-1 (GLUT1), and (D) P-glycoprotein (P-gp). Nuclei visualized with 4′,6-diamidino-2-phenylindole (DAPI) in blue.